Anthony F. Kreft

Acute γ-Secretase Inhibition Improves Contextual Fear Conditioning in the Tg2576 Mouse Model of Alzheimer's Disease

Thomas A. Comery, Robert Martone, Suzan Aschmies et al. · Journal of Neuroscience · 2005 · 212 citations · Full text

Acute Treatment, Neuropsychology, Affective Neuroscience +19

Begacestat (GSI-953): A Novel, Selective Thiophene Sulfonamide Inhibitor of Amyloid Precursor Protein γ-Secretase for the Treatment of Alzheimer’s Disease

Robert Martone, Hua Zhou, Kevin Atchison et al. · Journal of Pharmacology and Experimental Therapeutics · 2009 · 157 citations

Etodolac selectively inhibits human prostaglandin G/H synthase 2 (PGHS-2) versus human PGHS-1

Keith B. Glaser, Mei-Li Sung, Kim O’Neill et al. · European Journal of Pharmacology · 1995 · 149 citations

Molecular Pharmacology, Molecular Physiology, Biochemistry +6

Discovery of Begacestat, a Notch-1-Sparing γ-Secretase Inhibitor for the Treatment of Alzheimer’s Disease

Scott C. Mayer, Anthony F. Kreft, Boyd L. Harrison et al. · Journal of Medicinal Chemistry · 2008 · 109 citations · Full text

Stable Analogue 10, Alzheimer ’, Social Sciences +19

Inhibition of platelet and neutrophil phospholipase A2 by hydroxyeicosatetraenoic acids (HETEs) A novel pharmacological mechanism for regulating free fatty acid release

Joseph Chang, Eileen Blazek, Anthony F. Kreft et al. · Biochemical Pharmacology · 1985 · 72 citations

Inflammation, Thrombosis, Biochemistry +10